

Clinical Trials |
|
| For more information regarding our trials, please call our Patient Coordinator Stephanie Parker | 866.932.8588 | E-Mail |
|
Ovarian Cancers |
|
| A Phase I Trial of the Safety and Immunogenicity of a DNA Plasmid Based Vaccine Encoding the Amino Acids 1-163 of Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) in Patients with Advanced Ovarian Cancer (OC) Scientific Description | Clinical Description |
|
Page last updated 03/01/2012 |
|